Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease: one-year results of the ESSENCE Study. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q Wave Coronary Events. - Goodman,S.G.; Cohen,M.; Bigonzi,F. (J Am Coll Cardiol, 2000)